Rao Srinivas

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 11

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 442,000 shares

Expires not disclosed

F4 · derivative.exercise_price: At the Effective Time, each outstanding restricted stock unit ("RSU"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting).

F4 · price: At the Effective Time, each outstanding restricted stock unit ("RSU"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting).

F4 · derivative.exercise_date: At the Effective Time, each outstanding restricted stock unit ("RSU"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting).

F4 · derivative.expiration_date: At the Effective Time, each outstanding restricted stock unit ("RSU"), subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such RSU immediately prior to the Effective Time multiplied by (2) $6.75 and (B) one CVR for each share subject to such RSU immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 10

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,988,000 shares

Expires 2036-01-30

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 9

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,340,000 shares

Expires 2035-01-06

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 8

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 800,000 shares

Expires 2034-03-13

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 7

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 600,000 shares

Expires 2033-03-14

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 6

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 777,400 shares

Expires 2032-03-01

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 5

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,147,408 shares

Expires 2030-08-20

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 4

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 217,778 shares

Expires 2030-08-20

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · derivative · entry 3

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 650,795 shares

Expires 2030-08-20

F3 · price: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

F3 · derivative.exercise_date: At the Effective Time, each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one CVR for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting).

SEC source: 0001140361-26-036389 · form4.xml · nonDerivative · entry 2

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the "Company"), Eli Lilly and Company, an Indiana corporation ("Parent"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent ("Merger Sub"), on September 11, 2026, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving as a wholly owned subsidiary of Parent.

F2 · price: At the effective time of the Merger (the "Effective Time"), each share of the Company's common stock, par value $0.01 per share, issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, converted into the right to receive (i) $6.75 per share in cash, without interest, plus (ii) one contingent value right per share (each, a "CVR" and collectively, the "CVRs"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding.

SEC source: 0001140361-26-036389 · form4.xml · nonDerivative · entry 1

Rao Srinivas · CIK 0001860902 · Director · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the "Company"), Eli Lilly and Company, an Indiana corporation ("Parent"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent ("Merger Sub"), on September 11, 2026, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving as a wholly owned subsidiary of Parent.

F2 · price: At the effective time of the Merger (the "Effective Time"), each share of the Company's common stock, par value $0.01 per share, issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, converted into the right to receive (i) $6.75 per share in cash, without interest, plus (ii) one contingent value right per share (each, a "CVR" and collectively, the "CVRs"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding.

SEC source: 0001140361-26-003549 · form4.xml · derivative · entry 2

Rao Srinivas · CIK 0001860902 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 442,000

Underlying: Common Stock · 442,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027.

F2 · derivative.exercise_date: Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027.

F2 · derivative.expiration_date: Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027.

SEC source: 0001140361-26-003549 · form4.xml · derivative · entry 1

Rao Srinivas · CIK 0001860902 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,988,000

Underlying: Common Stock · 1,988,000 shares

Expires 2036-01-30

F1 · derivative.exercise_date: The stock option vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying the option on January 1, 2027 and as to the remaining 75% of the total number of shares in 36 substantially equal monthly installments thereafter.

SEC source: 0001140361-25-031571 · form4.xml · derivative · entry 2

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,777

Underlying: Common Shares · 217,777 shares

Expires 2030-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on January 20, 2021, vesting subject to performance conditions that were subsequently satisfied, as certified and approved by the board of directors of atai Life Sciences NV as of August 13, 2025. The portion of the Performance Options is fully vested and currently exercisable with respect to the shares reported herein.

F1 · derivative.exercise_date: No new stock options have been awarded. The transactions reported herein reflect vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on January 20, 2021, vesting subject to performance conditions that were subsequently satisfied, as certified and approved by the board of directors of atai Life Sciences NV as of August 13, 2025. The portion of the Performance Options is fully vested and currently exercisable with respect to the shares reported herein.

SEC source: 0001140361-25-031571 · form4.xml · derivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650,794

Underlying: Common Shares · 650,794 shares

Expires 2030-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on January 20, 2021, vesting subject to performance conditions that were subsequently satisfied, as certified and approved by the board of directors of atai Life Sciences NV as of August 13, 2025. The portion of the Performance Options is fully vested and currently exercisable with respect to the shares reported herein.

F1 · derivative.exercise_date: No new stock options have been awarded. The transactions reported herein reflect vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on January 20, 2021, vesting subject to performance conditions that were subsequently satisfied, as certified and approved by the board of directors of atai Life Sciences NV as of August 13, 2025. The portion of the Performance Options is fully vested and currently exercisable with respect to the shares reported herein.

SEC source: 0001140361-25-010114 · form4.xml · nonDerivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,942

F1 · shares: Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.

SEC source: 0001140361-25-009512 · form4.xml · derivative · entry 3

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 175,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.

SEC source: 0001140361-25-009512 · form4.xml · nonDerivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.

SEC source: 0001140361-25-000835 · form4.xml · derivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,340,000

Underlying: Common Shares · 2,340,000 shares

Expires 2035-01-06

F1 · derivative.exercise_date: The stock option shall vest as to 25% on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-112934 · ownership.xml · derivative · entry 6

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 709,952

Underlying: Common Shares · 709,952 shares

Expires 2030-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

F3 · price: The stock option vested as to 25% of the underlying shares on April 29, 2022, and the remaining underlying shares vest in 36 substantially equal monthly installments thereafter.

F3 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on April 29, 2022, and the remaining underlying shares vest in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-112934 · ownership.xml · derivative · entry 5

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,000

Underlying: Common Shares · 840,000 shares

Expires 2030-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

F2 · price: The stock option is fully vested and currently exercisable.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0000950170-24-112934 · ownership.xml · derivative · entry 4

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,307,408

Underlying: Common Shares · 1,307,408 shares

Expires 2030-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

F2 · price: The stock option is fully vested and currently exercisable.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0000950170-24-112934 · ownership.xml · derivative · entry 3

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 709,952 shares

Expires 2025-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

F3 · price: The stock option vested as to 25% of the underlying shares on April 29, 2022, and the remaining underlying shares vest in 36 substantially equal monthly installments thereafter.

F3 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on April 29, 2022, and the remaining underlying shares vest in 36 substantially equal monthly installments thereafter.

SEC source: 0000950170-24-112934 · ownership.xml · derivative · entry 2

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 840,000 shares

Expires 2025-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

F2 · price: The stock option is fully vested and currently exercisable.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0000950170-24-112934 · ownership.xml · derivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 1,307,408 shares

Expires 2025-08-20

F1 · security: No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.

F2 · price: The stock option is fully vested and currently exercisable.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

SEC source: 0001140361-24-018028 · form4.xml · nonDerivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,360

F1 · shares: Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.

SEC source: 0001140361-24-013626 · form4.xml · derivative · entry 4

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Shares · 175,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

SEC source: 0001140361-24-013626 · form4.xml · nonDerivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

SEC source: 0001140361-24-013626 · form4.xml · derivative · entry 3

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Shares · 800,000 shares

Expires 2034-03-13

F2 · derivative.exercise_date: The stock option shall vest as to 25% of the underlying shares on January 1, 2025, and in 36 substantially equal monthly installments thereafter.

SEC source: 0000899243-23-008783 · doc4.xml · derivative · entry 2

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Shares · 350,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

SEC source: 0000899243-23-008783 · doc4.xml · derivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Shares · 600,000 shares

Expires 2033-03-14

F1 · derivative.exercise_date: The stock option shall vest as to 25% of the underlying shares on March 14, 2024, and in 36 substantially equal monthly installments thereafter.

SEC source: 0000899243-22-009378 · doc4.xml · derivative · entry 3

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 519,240

Underlying: Common Shares · 519,240 shares

Expires 2032-03-01

F3 · derivative.exercise_date: The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

SEC source: 0000899243-22-009378 · doc4.xml · derivative · entry 2

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 840,000

Underlying: Common Shares · 840,000 shares

Expires 2025-08-20

F2 · derivative.exercise_date: The stock option vests and is exercisable as to 25% of the underlying shares on August 21, 2021, and as to 2.083% of the underlying shares in 36 monthly installments commencing on September 1, 2021.

SEC source: 0000899243-22-009378 · doc4.xml · derivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,307,408

Underlying: Common Shares · 1,307,408 shares

Expires 2025-08-20

F1 · derivative.exercise_date: The stock option vests and is exercisable as to 25% of the underlying shares on April 1, 2020, and as to 2.083% of the underlying shares in 36 monthly installments commencing on May 1, 2020.

SEC source: 0000899243-21-025734 · doc4.xml · nonDerivative · entry 1

Rao Srinivas · CIK 0001860902 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 3,500